| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 03/06/2007 | US7186870 Cyclization by reacting 4-(2-CHLORO-4-TRIFLUOROMETHYL-PHENYL)-4-CYANO-BUT-3-ENOIC ACID METHYL ESTER in the presence of a palladium catalyst and a base; chemical intermediates for preparing 10-AZA-TRICYCLO[6.3.1.02,7] drugs; bind nicotinic acetylcholine receptor, modulate cholinergic function |
| 03/06/2007 | US7186841 Antiinflammation agents |
| 03/06/2007 | US7186832 anticancer agents; antidiabetic agents; autoimmune disease; restenosis; antiarthritic agents; skin disorders; cardiovascular disorders; antiinflammatory agents |
| 03/06/2007 | US7186830 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
| 03/06/2007 | US7186753 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents |
| 03/06/2007 | US7186743 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics |
| 03/06/2007 | US7186732 For therapy and prophylaxis of upper airway allergic response, nasal congestion, or allergic rhinitis, dementia, mild cognitive impairment (pre-dementia), cognitive dysfunction, schizophrenia, depression, manic disorders |
| 03/06/2007 | US7186731 2-cyanopyrrolidinecarboxamide compound |
| 03/06/2007 | US7186730 Bicyclic nitrogen-containing heterocyclic derivatives for use as antibacterials |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186721 Substituted hexahydropyrrolo[1,2-a]pyrazines, octahydropyrido[1,2-a]-pyrazines and decahydropyrazino[1,2-a]azepines |
| 03/06/2007 | US7186716 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors |
| 03/06/2007 | US7186714 administering drugs such as 3-[2-(Cyclopentylamino)-4-pyrimidinyl]-2-(4-fluorophenyl)imidazo[1,2-a]pyridin-8-amine, for therapy of viral diseases caused by DNA viruses |
| 03/06/2007 | US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders |
| 03/06/2007 | US7186709 Subjecting a vinyl ethers and an unsaturated ketoester to suitable conditions to generate a scaffold having the core dihydropyrancarboxamide or dihydropyrancarboxylic ester or acid; anticarcinogenic agents |
| 03/06/2007 | US7186469 Bathophenanthroline compound and EL device |
| 03/06/2007 | CA2294990C Pharmaceutical compositions and methods for effecting dopamine release |
| 03/01/2007 | WO2007025090A2 Heterobicyclic and - tricyclic inhibitors of mapk/erk kinase |
| 03/01/2007 | WO2007025069A2 Diazaspirodecane orexin receptor antagonists |
| 03/01/2007 | WO2007024945A1 Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
| 03/01/2007 | WO2007024814A1 HETEROARYL-SUBSTiTUTED DIAZATRICYCLOALKANES, METHODS FOR ITS PREPARATION AND USE THEREOF |
| 03/01/2007 | WO2007024789A1 Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use |
| 03/01/2007 | WO2007023504A1 Process for the preparation of imidazopyridines |
| 03/01/2007 | WO2007023382A2 Pyrimidine amino pyrazole compounds, potent kinase inhibitors |
| 03/01/2007 | WO2007023110A2 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | WO2007023105A1 FUSED PYRAZOLE AS p38 MAP KINASE INHIBITORS |
| 03/01/2007 | WO2007022946A1 Heterocyclic compounds and their use as binding partners for 5-ht5 receptors |
| 03/01/2007 | WO2007003961A3 Gpcr agonists |
| 03/01/2007 | WO2006138347A3 Androgen receptor modulator compounds and methods |
| 03/01/2007 | WO2006114520A3 Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof |
| 03/01/2007 | WO2006047528A3 Pyrazolobenzamides and derivatives as factor xa inhibitors |
| 03/01/2007 | WO2006014325A3 C-met modulators and method of use |
| 03/01/2007 | WO2005117876A8 Dual small molecule inhibitors of cancer and angiogenesis |
| 03/01/2007 | US20070049620 Cyclic tertiary amine compound |
| 03/01/2007 | US20070049616 Organic compounds |
| 03/01/2007 | US20070049615 3-(6-Chloro-pyridin-3-ylmethyl)-4-phenyl-1H-pyrrolo[2,3-b]pyridine; molecular scaffolds |
| 03/01/2007 | US20070049593 Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
| 03/01/2007 | US20070049582 Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression |
| 03/01/2007 | US20070049580 Anxiolytic agents with reduced sedative and ataxic effects |
| 03/01/2007 | US20070049574 4,5-Dicyclopropyl-1-methyl-2-phenyl-1,2-dihydro-pyrazol-3-one; 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1); 4-Cyclopropyl-5-(2,2-difluoro-cyclopropyl)-1-methyl-2-(2-trifluoromethyl-phenyl)-1,2-dihydro-pyrazol-3-one; |
| 03/01/2007 | US20070048728 Hydroxylases and modulators thereof |
| 03/01/2007 | US20070048215 Chemical compound and assay |
| 03/01/2007 | CA2620254A1 P38 map kinase inhibitors and methods for using the same |
| 03/01/2007 | CA2620104A1 Fused pyrazole as p38 map kinase inhibitors |
| 03/01/2007 | CA2620052A1 Indenoisoquinolinone analogs and methods of use thereof |
| 03/01/2007 | CA2619972A1 Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use |
| 03/01/2007 | CA2619660A1 Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase |
| 03/01/2007 | CA2619111A1 Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 03/01/2007 | CA2618700A1 Heteroaryl-substituted diazatricycloalkanes, methods for its preparation and use thereof |
| 02/28/2007 | EP1757670A2 Organic electroluminescent element |
| 02/28/2007 | EP1757608A1 New benzazepine derivatives, medicaments containing the same and their use in the preparation of medicaments |
| 02/28/2007 | EP1757605A1 Cyclic amine compound |
| 02/28/2007 | EP1757594A1 Quinazoline derivative |
| 02/28/2007 | EP1756129A1 Novel dna threading intercalators |
| 02/28/2007 | EP1756109A1 Novel indole derivatives as selective androgen receptor modulators (sarms) |
| 02/28/2007 | EP1756108A2 Azaindoles useful as inhibitors of rock and other protein kinases |
| 02/28/2007 | EP1756107A2 Aryl-substituted piperazine derivatives |
| 02/28/2007 | EP1756106A1 Cyclohexylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 02/28/2007 | EP1756105A1 Substituted imidazo[1,2-a]pyridine compounds and drugs containing substituted imidazo[1,2-a]pyridine compounds |
| 02/28/2007 | EP1756104A1 Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands |
| 02/28/2007 | EP1756103A2 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors |
| 02/28/2007 | EP1756102A1 8-PHENOXY-GammaCARBOLINE DERIVATIVES |
| 02/28/2007 | EP1756101A2 Androgen receptor modulators and method of treating disease using the same |
| 02/28/2007 | EP1756084A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 02/28/2007 | EP1756069A2 Hiv integrase inhibitors |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1756044A1 Therapeutic compounds |
| 02/28/2007 | EP1756037A2 Amino alcohol derivatives and their activity as renin inhibitors |
| 02/28/2007 | EP1755603A2 3,3-disubstituted tetrahydropyranyl cyclopentyl amide modulators of chemokine receptor activity |
| 02/28/2007 | EP1509522B1 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 02/28/2007 | EP1507776B1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders |
| 02/28/2007 | EP1465893B1 Derivatives of 5-(pyridin-3-yl)-1-azabicyclo (3.2.1) octane, the preparation thereof and the application of same in therapeutics |
| 02/28/2007 | EP1441734B1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1370531B1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 02/28/2007 | EP1309592B9 Substituted pyrazoles |
| 02/28/2007 | EP1178988B1 Compounds and therapeutic methods |
| 02/28/2007 | EP1102753B1 Pyrazoles as estrogen receptor modulators |
| 02/28/2007 | CN1922189A Spirocyclic cyclohexane derivatives with affinity for the ORL1-receptor |
| 02/28/2007 | CN1922186A Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands |
| 02/28/2007 | CN1922178A Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds |
| 02/28/2007 | CN1922177A Aryl- and heteroaryl-piperidinecarboxylate derivatives, the preparation and the use thereof in the form of FAAH enzyme inhibitors |
| 02/28/2007 | CN1922174A 病毒聚合酶抑制剂 Viral polymerase inhibitor |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922169A Spirocyclic heterocyclic derivatives and methods of their use |
| 02/28/2007 | CN1922155A Novel sulfone amide derivative |
| 02/28/2007 | CN1922141A Novel heterocyclic compound |
| 02/28/2007 | CN1921854A Heterocyclic GABAA subtype selective receptor modulators |
| 02/27/2007 | US7183415 Melanin-concentrating hormone antagonistic action for treating obesity, for example 4'-fluoro-N-[8-methyl-3-(1-pyrrolidinylmethyl)-7-quinolinyl][1,1'-biphenyl]-4-carboxamide |
| 02/27/2007 | US7183413 Aminoquinoline compounds |
| 02/27/2007 | US7183412 Ester or amide derivatives |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183313 Keto cannabinoids with therapeutic indications |
| 02/27/2007 | US7183284 Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents |
| 02/27/2007 | US7183282 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders |
| 02/27/2007 | US7183273 Administering compounds such as N-(2-pyridinylmethyl)-N'-(6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-9-yl)-1,4-benzenedimethanamine for therapy of disease mediated by a chemokine receptor |
| 02/27/2007 | US7183270 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/27/2007 | CA2163400C Process for the preparation of organic pigments |
| 02/22/2007 | WO2007022529A2 Method of treating inflammatory diseases |
| 02/22/2007 | WO2007022305A2 2-aminoimidazopyridines for treating neurodegenerative diseases |